Rheumatoid Arthritis News

Rheumatoid arthritis is independently linked to worse prognosis following myocardial infarction, with disease duration and corticosteroid use predicting mortality after myocardial infarction, according to data published in Rheumatology.

Patients on methotrexate for psoriasis or psoriatic arthritis were more likely to develop liver complications than those taking it for rheumatoid arthritis, according to a study.

Electronic monitoring, using caps that record when a pill bottle is opened, contradicts pill counts in measuring drug adherence among patients aged 65 years and older with rheumatoid arthritis, according to data published in Rheumatology.

The last 2 decades of rheumatology management, including the treatment of rheumatoid arthritis, have been marked by improved drugs aiming at increasingly more refined therapeutic targets.

Overall multibiomarker disease activity scores are insufficient for determining rheumatoid arthritis disease activity following repository corticotropin injection, according to data published in Arthritis Care & Research.

Patient voices are growing louder in rheumatology. The calls for shared decision-making and a dual target strategy of assessing disease remission are increasing with a body of evidence showing that when patient needs are met, outcomes improve.

Twitter use revealed “early signals” of drug rationing and other critical behavior changes in patients with rheumatic diseases as they navigated the early months of the COVID-19 pandemic, according to data published in Rheumatology.

During the early months of the COVID-19 pandemic, increased all-cause mortality in patients with rheumatoid arthritis and other inflammatory joint diseases largely mirrored that of the general population, according to data.

Arthritis and hypertension are the two most prevalent chronic conditions among U.S. veterans aged 25 years and older, according to data published by CDC researchers in National Health Statistics Report.

The simultaneous use of oral glucocorticoids and proton pump inhibitors is associated with a 1.6-fold increased risk for osteoporotic fractures in patients aged 50 years and older with rheumatoid arthritis, according to data.